2013 update in nephrology

Vasopressin antagonists show for the first time a beneficial effect on ADPKD cyst growth and renal function in a large cohort of patients. In ANCA vasculitis, the 18 months follow-up of Rituximab treatment for induction confirms the safety and efficacy of this therapeutic option. Two studies brought...

Full description

Saved in:
Bibliographic Details
Published inRevue médicale suisse Vol. 10; no. 412-413; p. 74
Main Authors de Seigneux, Sophie, Saudan, Patrick
Format Journal Article
LanguageFrench
Published Switzerland 15.01.2014
Subjects
Acute Kidney Injury - therapy
Algorithms
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy
Humans
Nephrology - methods
Nephrology - trends
Polycystic Kidney Diseases - therapy
Renal Dialysis
Online AccessGet full text
ISSN1660-9379

Cover

More Information
Summary:Vasopressin antagonists show for the first time a beneficial effect on ADPKD cyst growth and renal function in a large cohort of patients. In ANCA vasculitis, the 18 months follow-up of Rituximab treatment for induction confirms the safety and efficacy of this therapeutic option. Two studies brought some answers to what is the more appropriate intravenous fluid strategy to decrease the incidence of acute kidney injury in critically ill patients. Regarding mortality in dialysed patients, inconclusive results about the use of calcimimetics to decrease cardiovascular mortality have been reported but there is good evidence that hemodiafiltration with high ultrafiltration volume can decrease significantly the mortality in these
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ISSN:1660-9379